Quinagolide - a valuable treatment option for hyperprolactinaemia -- Barlier and Jaquet 154 (2): 187 -- European Journal of Endocrinology
CAB doesn't seem to be getting the PRL level down as much as we'd like, even at 0.75mg x 4/week. We're considering switching to QUI (Quinagolide). QUI appears to offer similar effectiveness in most studies. In addition, it's not an ergot-derived drug, so it should not have some of the risks that Bromocriptine and CAB have.
Showing posts with label Quinagolide. Show all posts
Showing posts with label Quinagolide. Show all posts
Subscribe to:
Posts (Atom)
Posts
